RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 13, 2015

Total Value: $696M (100.0% shares, 0.0% debt)

Holdings (47)

— ACHILLION PHARMACEUTICALS INC 11.6%
Value $81.08M Shares 11,733,815 Share Price $6.91 Est. Cost/Share $6.36 Unrealized @ Report Date —
— AXOVANT SCIENCES LTD 9.3%
Value $64.6M Shares 5,000,000 Share Price $12.92 Est. Cost/Share $20.38 Unrealized @ Report Date —
— DYAX CORP 7.0%
Value $48.7M Shares 2,551,193 Share Price $19.09 Est. Cost/Share $8.24 Unrealized @ Report Date —
COLL COLLEGIUM PHARMACEUTICAL INC 4.9%
Value $34.34M Shares 1,553,175 Share Price $22.11 * Est. Cost/Share $17.29 Unrealized @ Report Date +4.1%
TGTX TG THERAPEUTICS INC 4.5%
Value $31.5M Shares 3,124,480 Share Price $10.08 * Est. Cost/Share $10.99 Unrealized @ Report Date +35.6%
— REGULUS THERAPEUTICS INC 3.8%
Value $26.42M Shares 4,039,823 Share Price $6.54 Est. Cost/Share $15.20 Unrealized @ Report Date —
CHRS COHERUS BIOSCIENCES INC 3.8%
Value $26.15M Shares 1,305,020 Share Price $20.04 * Est. Cost/Share $14.11 Unrealized @ Report Date +115.7%
ASND ASCENDIS PHARMA A S 3.7%
Value $25.86M Shares 1,461,268 Share Price $17.70 Est. Cost/Share $17.50 Unrealized @ Report Date —
— ZOGENIX INC 3.3%
Value $22.67M Shares 1,679,500 Share Price $13.50 Est. Cost/Share $13.50 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 3.1%
Value $21.56M Shares 1,532,151 Share Price $14.07 Est. Cost/Share $14.07 Unrealized @ Report Date —
— PROTEON THERAPEUTICS INC 3.0%
Value $20.96M Shares 1,506,872 Share Price $13.91 Est. Cost/Share $11.67 Unrealized @ Report Date —
— AIMMUNE THERAPEUTICS INC 2.9%
Value $20.01M Shares 790,200 Share Price $25.32 Est. Cost/Share $25.32 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 2.9%
Value $19.94M Shares 2,428,571 Share Price $8.21 Est. Cost/Share $28.25 Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS INC 2.8%
Value $19.27M Shares 457,142 Share Price $42.16 Est. Cost/Share $42.16 Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 2.7%
Value $18.74M Shares 878,348 Share Price $21.34 Est. Cost/Share $26.49 Unrealized @ Report Date —
ARDX ARDELYX INC 2.6%
Value $18.39M Shares 1,064,013 Share Price $17.28 * Est. Cost/Share $12.61 Unrealized @ Report Date +48.0%
— CIDARA THERAPEUTICS INC 2.2%
Value $15.02M Shares 1,180,570 Share Price $12.72 Est. Cost/Share $13.98 Unrealized @ Report Date —
— BLUEBIRD BIO INC 2.1%
Value $14.32M Shares 167,367 Share Price $85.55 Est. Cost/Share $49.44 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.0%
Value $13.64M Shares 1,196,603 Share Price $11.40 * Est. Cost/Share $9.01 Unrealized @ Report Date +48.2%
— INTRA CELLULAR THERAPIES INC 1.8%
Value $12.59M Shares 314,349 Share Price $40.04 Est. Cost/Share $40.04 Unrealized @ Report Date —
— PRONAI THERAPEUTICS INC 1.8%
Value $12.41M Shares 604,982 Share Price $20.52 Est. Cost/Share $20.52 Unrealized @ Report Date —
— ALCOBRA LTD 1.6%
Value $11.07M Shares 1,832,911 Share Price $6.04 Est. Cost/Share $6.46 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.3%
Value $8.898M Shares 1,518,460 Share Price $5.86 Est. Cost/Share $3.00 Unrealized @ Report Date —
— NEURODERM LTD 1.3%
Value $8.785M Shares 425,000 Share Price $20.67 Est. Cost/Share $20.67 Unrealized @ Report Date —
NTRA NATERA INC 1.2%
Value $8.501M Shares 783,521 Share Price $10.85 * Est. Cost/Share $16.90 Unrealized @ Report Date 0.0%
XNCR XENCOR INC 1.2%
Value $8.315M Shares 679,885 Share Price $12.23 * Est. Cost/Share $11.47 Unrealized @ Report Date +70.6%
SGMO SANGAMO BIOSCIENCES INC 1.2%
Value $8.152M Shares 1,445,430 Share Price $5.64 * Est. Cost/Share $9.09 Unrealized @ Report Date -9.3%
— TENAX THERAPEUTICS INC 1.2%
Value $8.011M Shares 2,670,300 Share Price $3.00 Est. Cost/Share $3.92 Unrealized @ Report Date —
— NIVALIS THERAPEUTICS INC 1.1%
Value $7.949M Shares 612,863 Share Price $12.97 Est. Cost/Share $15.15 Unrealized @ Report Date —
— ZYNERBA PHARMACEUTICALS INC 1.1%
Value $7.513M Shares 525,000 Share Price $14.31 Est. Cost/Share $14.31 Unrealized @ Report Date —
— SERES THERAPEUTICS INC 1.0%
Value $7.311M Shares 246,645 Share Price $29.64 Est. Cost/Share $41.50 Unrealized @ Report Date —
— AKARI THERAPEUTICS PLC 0.9%
Value $6.333M Shares 263,921 Share Price $24.00 Est. Cost/Share $24.00 Unrealized @ Report Date —
RARE ULTRAGENYX PHARMACEUTICAL INC 0.8%
Value $5.4M Shares 56,067 Share Price $96.31 * Est. Cost/Share $114.50 Unrealized @ Report Date 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 0.7%
Value $5.065M Shares 63,026 Share Price $80.36 * Est. Cost/Share $111.10 Unrealized @ Report Date 0.0%
— BELLICUM PHARMACEUTICALS INC 0.7%
Value $4.587M Shares 315,704 Share Price $14.53 Est. Cost/Share $9.10 Unrealized @ Report Date —
— AGILE THERAPEUTICS INC 0.6%
Value $4.251M Shares 630,702 Share Price $6.74 Est. Cost/Share $9.27 Unrealized @ Report Date —
— ARCA BIOPHARMA INC 0.6%
Value $4.024M Shares 811,227 Share Price $4.96 Est. Cost/Share $4.96 Unrealized @ Report Date —
— VITAE PHARMACEUTICALS INC 0.5%
Value $3.536M Shares 321,161 Share Price $11.01 Est. Cost/Share $11.01 Unrealized @ Report Date —
— EPIZYME INC 0.4%
Value $2.92M Shares 227,092 Share Price $12.86 Est. Cost/Share $12.86 Unrealized @ Report Date —
— AURIS MED HLDG AG 0.2%
Value $1.665M Shares 467,572 Share Price $3.56 Est. Cost/Share $5.77 Unrealized @ Report Date —
— APPLIED GENETIC TECHNOL CORP 0.2%
Value $1.591M Shares 121,100 Share Price $13.14 Est. Cost/Share $13.14 Unrealized @ Report Date —
— NOVAVAX INC 0.2%
Value $1.146M Shares 162,060 Share Price $7.07 Est. Cost/Share $2.24 Unrealized @ Report Date —
— VICAL INC 0.1%
Value $958K Shares 2,084,078 Share Price $0.46 Est. Cost/Share $1.09 Unrealized @ Report Date —
— BENITEC BIOPHARMA LTD 0.1%
Value $864K Shares 140,548 Share Price $6.15 Est. Cost/Share $6.15 Unrealized @ Report Date —
— DURECT CORP 0.1%
Value $745K Shares 381,800 Share Price $1.95 Est. Cost/Share $2.39 Unrealized @ Report Date —
— WAFERGEN BIO-SYSTEMS INC 0.0%
Value $279K Shares 205,400 Share Price $1.36 Est. Cost/Share $4.35 Unrealized @ Report Date —
— AMPLIPHI BIOSCIENCES CORP 0.0%
Value $257K Shares 65,100 Share Price $3.95 Est. Cost/Share $3.95 Unrealized @ Report Date —